|Home | About | Journals | Submit | Contact Us | Français|
In the uterus, the formation of new maternal blood vessels in the stromal compartment at the time of embryonic implantation is critical for the establishment and maintenance of pregnancy. Although uterine angiogenesis is known to be influenced by the steroid hormones estrogen (E) and progesterone (P), the underlying molecular pathways remain poorly understood. Here, we report that the expression of connexin 43 (Cx43), a major gap junction protein, is markedly enhanced in response to E in uterine stromal cells surrounding the implanted embryo during the early phases of pregnancy. Conditional deletion of the Cx43 gene in these stromal cells and the consequent disruption of their gap junctions led to a striking impairment in the development of new blood vessels within the stromal compartment, resulting in the arrest of embryo growth and early pregnancy loss. Further analysis of this phenotypical defect revealed that loss of Cx43 expression resulted in aberrant differentiation of uterine stromal cells and impaired production of several key angiogenic factors, including the vascular endothelial growth factor (Vegf). Ablation of CX43 expression in human endometrial stromal cells in vitro led to similar findings. Collectively, these results uncovered a unique link between steroid hormone-regulated cell-cell communication within the pregnant uterus and the development of an elaborate vascular network that supports embryonic growth. Our study presents the first evidence that Cx43-type gap junctions play a critical and conserved role in modulating stromal differentiation, and regulate the consequent production of crucial paracrine signals that control uterine neovascularization during implantation.
During the early stages of pregnancy, the steroid hormones estrogen (E) and progesterone (P) orchestrate the structural and functional changes in the mammalian uterus that enable the blastocyst to attach to it, initiating the process of implantation (Psychoyos, 1973; Yoshinaga, 1988; Parr and Parr, 1989; Weitlauf, 1994). In the mouse and the human, as the embryo invades into the stromal compartment, the fibroblastic stromal cells undergo differentiation into a unique secretory tissue, known as the decidua. This transformation process, known as decidualization, is crucial for executing the extensive tissue remodeling that ensures proper maternal-fetal interactions, leading to the establishment of pregnancy. Decidualization is also accompanied by the creation of an extensive vascular network within the stromal bed that supports embryonic and placental growth and maintains early pregnancy (Cross et al., 1994; Irwin and Giudice, 1999; Carson et al., 2000).
During angiogenesis, new blood vessels are generated by the extension of pre-existing vessels into avascular space. This process involves the local degradation of the vascular basal membrane by proteases, proliferation and migration of endothelial cells, and assembly of these cells into new vessels (Folkman, 1995; Hyder and Stancel, 1999). In the female reproductive system, an active angiogenesis is required to support the cyclic remodeling of the uterus. In the human and the non-human primates, the spiral arteries that supply the functionalis layer of the endometrium increase in length, branching and coiling during each menstrual cycle as the endometrium is regenerated (Hyder and Stancel, 1999). In rodents, a link between the steroid-driven stromal differentiation program and active neovascularization within the pregnant uterus has long been speculated, although the underlying mechanisms are unknown. One of the earliest signs of a uterine response to an angiogenic stimulus is an increase in microvascular permeability at the sites of implantation (Chakraborty et al., 1995; Rockwell et al., 2002). E is recognized as a regulator of this phenomenon (Chakraborty et al., 1995; Rockwell et al., 2002). However, the precise nature of the hormone-regulated pathways that influence uterine angiogenesis remains unclear and controversial. Particularly intriguing is a previous report that E is an inhibitor and P is a stimulator of uterine angiogenesis (Ma et al., 2001). As this study was performed using ovariectomized non-pregnant mice following treatment with steroid hormones, the relevance of these findings under normal pregnancy conditions is questionable. A major challenge in reproductive medicine is, therefore, to gain a clear understanding of the steroid hormone-regulated pathways that control pregnancy-associated endometrial neovascularization in the stromal compartment. The present study was undertaken to uncover and functionally characterize these pathways.
Mice were maintained in the designated animal care facility at the University of Illinois College of Veterinary Medicine according to the institutional guidelines for the care and use of laboratory animals. For mating studies, Cx43fl/fl and Cx43d/d female mice were housed with wild-type C57BL/6 male mice (Charles Rivers). The presence of a vaginal plug after mating was designated as day 1 of pregnancy.
In order to induce superovulation, 7- to 8-week-old female mice were injected intraperitoneally with 5 IU of pregnant mare serum gonadotrophin (PMSG) and 48 hours later with 5 IU of human chorionic gonadotropin (hCG). The mice were killed 16–18 hours post-hCG administration, and oocytes were flushed from the oviducts and counted.
To induce and maintain delayed implantation, mice were ovariectomized on day 4 (morning) of pregnancy and injected daily with P (2 mg) from days 5–7. To terminate delayed implantation and induce blastocyst attachment, the P-primed delayed implanting mice were given an injection of E (50 ng) on the fourth day of the delay (day 8). Mice were killed at different time points after E injection and uteri were collected.
Decidualization was experimentally induced in non-pregnant mice as described previously (Cheon et al., 2004). Mice were first ovariectomized. Two weeks following ovariectomy, animals were injected with 100 ng of E in 0.1 ml of sesame oil for 3 consecutive days. This was followed by daily injections of 1 mg of P for 3 consecutive days. Decidualization was then initiated in one horn by injection of 50 µl oil. The other horn was left unstimulated. The animals were treated with P for an additional 6 days poststimulation and then killed to collect the uterine tissue.
For Cx43, Pecam, Ki67 and Vegf immunostaining, uterine sections were obtained and flash frozen. Samples were embedded in OCT, cryosections were taken at 8 µm and subjected to immunostaining with antibodies against Cx43 (Zymed), Pecam1 (BD Biosciences), Ki67 (Santa Cruz Biotech) and Vegf (Santa Cruz Biotech). For double immunostaining against Pecam1 and Cx43, uterine tissues were collected from mice on day 8 of pregnancy and flash frozen in liquid nitrogen. Incubations with primary antibody were carried out overnight at 4°C (1:1000 dilution of rat anti-Pecam1 antibody, Pharmingen 557355; 1:500 dilution of a rabbit polyclonal antibody against Cx43, Zymed 71-0700), using frozen sections. Secondary antibody incubations were carried out for 2 hours at room temperature with a 1:200 dilution of fluorescently conjugated secondary antibodies: TRITC-conjugated goat anti-rabbit antibody (Sigma T6778) and FITC-conjugated goat anti-rat antibody (Sigma F6258). Sections were washed three times for 5 minutes each in PBS.
Primary human endometrial stromal cells were isolated from endometrial biopsies of fertile women and immortalized by stable transfection of a gene coding for an essential catalytic protein subunit of human telomerase reverse transcriptase (Krikun et al., 2004). These telomerase-expressing stromal cells (termed HESC-T) were stably transfected with retroviral vectors expressing Cx43 small interfering RNA (siRNA) and a control Cx43 non-silencing sequence (Shao et al., 2005). The siRNA insert-containing retroviral vectors were first transduced into PT67 retro-packaging cells (BD Biosciences) to generate infectious viral particle-containing supernatant. Filtered supernatants were then used to infect HESC-T cells and the infected cells selected in media containing 50 µg/ml hygromycin. Cells transfected with a control non-silencing siRNA and Cx43 siRNA are designated as HESC-TC and HESC-T3, respectively. The cells were grown in DMEM/F-12 medium containing 5% charcoal-stripped FBS. To induce in vitro decidualization, the cells were treated with or without a hormone cocktail containing 1 nM E, 1 mM P and 0.5 mM 8-bromo-cAMP for 7–11 days. Cell culture supernatants were collected, and prolactin and VEGF were measured using standardized ELISA kits. Three independent experiments were performed to assure reproducibility and the data are presented as mean±s.d. Comparisons between HESC-TC and HESC-T3 cells were made using two-tailed Student’s t-tests, with a significance threshold set at P=0.05.
Donor cells were double labeled with the fluorescent dyes calcein (gap junction permeable dye) and Dil (gap junction impermeable dye). These cells were then placed in contact with unloaded cells in a monolayer. Dye transfer was visualized after 2 hours. The cells that fluoresce both green (calcein) and red (Dil) are the dual-loaded donor cells, whereas those fluorescing only green were originally unlabeled in the monolayer and now demonstrate functional coupling.
To identify steroid-regulated gene networks with functional relevance in implantation, we used a delayed implantation mouse model in which implantation is induced by an acute administration of E to ovariectomized pregnant mice maintained in the presence of P (Yoshinaga and Adams, 1966; Gidley-Baird, 1981). This hormonal profile mimics the transient preimplantation surge of E that is essential for implantation in the rodents. Gene expression profiling using Affymetrix mouse microarrays (430 2.0 Array) revealed that connexin 43 (Cx43), also known as gap junction protein alpha 1 (Gja1), is one of the many genes whose expression is altered in P-primed uteri in response to E (Mantena et al., 2006) (M.K.B. and I.C.B., unpublished). The connexins are a family of transmembrane proteins that form hexameric assemblies in the plasma membrane to create gap junctions, regulating intercellular communication. Cx43 is the principal and most well-studied component of the gap junctions (Kumar and Gilula, 1996; Bruzzone et al., 1996).
We first confirmed the hormonal regulation of Cx43 expression in pregnant uterus by performing immunohistochemical analysis. We observed that E treatment dramatically enhances the expression of Cx43 protein in the uterine stromal compartment during delayed implantation (Fig. 1A). Our findings are also in agreement with previous reports that Cx43 expression in the uterus is primarily under E regulation (Grummer et al., 2004). When we examined the profile of Cx43 protein expression in mouse uterus during normal pregnancy, it was undetectable in undifferentiated stromal cells during the preimplantation period (Fig. 1B, parts a,b). However, on day 5 of pregnancy, within 12 hours of the initiation of implantation, a marked induction in Cx43 protein expression was observed in the stromal cells in the primary decidual zone immediately surrounding the implanting embryo (Fig. 1B, parts c,d). As pregnancy progressed to day 7, Cx43 expression intensified and spread to the secondary decidual zone (Fig. 1B, parts e,f). The close spatio-temporal relationship between Cx43 expression and the progression of decidualization raised the possibility that stromal gap junctions harboring this protein may play an important role during the differentiation process.
To investigate the function of Cx43 during embryo implantation, we employed a loss-of-function approach using genetically engineered mice. Cx43-null mice exhibit a perinatal lethal phenotype due to impaired cardiovascular development (Reaume et al., 1995). To circumvent this problem, we created a conditional knockout of the Cx43 gene in the uterus of adult mice by employing the Cre-LoxP strategy. Transgenic mice expressing Cre under the control of progesterone receptor (PR) promoter were used previously to ablate ‘floxed’ genes in the uterus (Lee et al., 2006; Mukherjee et al., 2006; Lee et al., 2007). We crossed these PR-Cre mice with those harboring the ‘floxed’ Cx43 gene (Cx43fl/fl) to create the Cx43d/d mice in which the Cx43 gene is deleted in uterine cells expressing PR. The ablation of the Cx43 gene in the uterine tissue of Cx43d/d mice during pregnancy was confirmed when uterine sections obtained from these mice failed to show any Cx43 protein expression in the stromal cells surrounding the implanted embryo (Fig. 2).
An 8-month breeding study demonstrated that female Cx43d/d mice exhibit severe fertility defects (Table 1). Our study revealed that ~50% of a cohort (n=13) of Cx43d/d female mice analyzed during this breeding experiment never gave birth, although they mated normally with wild-type males. Furthermore, the Cx43d/d mice that did give birth exhibited a more than 60% reduction in the number of pups per litter when compared with control Cx43fl/fl mice. Overall, these results indicated that the conditional excision of the Cx43 gene led to an ~80% reduction in the total number of pups born per Cx43d/d female compared with a Cx43fl/fl female in the breeding program (35/13 versus 419/37). Superovulation experiments indicated that Cx43d/d mice ovulate normally and release oocytes in quantities comparable to those of Cx43fl/fl mice (Table 1). In agreement with normal ovarian activity, serum P levels were normal in the Cx43d/d mice on day 8 of pregnancy (Table 1). Collectively, these data suggest that the observed fertility defect in Cx43d/d mice is not likely to be due to an impairment of the hypothalamic-pituitary-ovarian axis.
Further analysis indicated that the Cx43d/d mice are able to initiate embryo implantation and support pregnancy up to day 7 of gestation. Implanted embryos embedded in the stroma were observed in both Cx43fl/fl and Cx43d/d mice (Fig. 3A, parts a,c). However, starting on day 8 of pregnancy in Cx43d/d mice, we detected distinct signs of arrest of embryonic growth and noted embryo loss or resorption. Morphological analysis of uterine sections obtained from these mice on day 8 of pregnancy showed abnormally small embryos compared with those of Cx43fl/fl mice (compare parts b and d in Fig. 3A). An examination of the histological sections from day 8 pregnant uteri revealed a severe impairment in the development of an angiogenic network in the stromal bed of Cx43-deficient uteri (Fig. 3A, parts e,f). When the uterine sections of pregnant Cx43fl/fl mice were subjected to immunohistochemistry using an antibody against platelet/endothelial cell adhesion molecule (Pecam), a marker of endothelial cells, they displayed a well-developed vascular network spanning the endometrial bed that surrounds the implanted embryo on day 7 or day 8 of pregnancy (Fig. 3B, parts a–c). The Pecam immunostaining, however, was reduced drastically in uterine sections of Cx43d/d mice on day 7 or day 8 of pregnancy, indicating that only a rudimentary vasculature formed in the mutant uteri (Fig. 3B, parts d–f). It is important to mention here that immunofluorescence experiments using differently labeled antibodies against Pecam and Cx43 indicated that during early pregnancy Cx43 expression occurs solely in the uterine stromal cells and not in the endothelial cells (Fig. 3C). These results support the concept that the loss of Cx43 expression in the stromal gap junctions is responsible for the drastic reduction in the endothelial cell population in the pregnant uterus.
The lack of endothelial cell proliferation in Cx43-deficient uteri was further ascertained by immunostaining for Ki67, a marker for cell proliferation (Fig. 3D). Whereas the uterine sections obtained from Cx43fl/fl mice on day 8 of pregnancy exhibited robust Ki67 immunostaining in endothelial cells, consistent with microvascular proliferation (Fig. 3D, part a), those obtained from mutant animals showed greatly reduced Ki67 staining (Fig. 3D, part b), confirming a severely compromised endothelial cell proliferation in the absence of stromal Cx43 expression.
To gain further insight into the mechanisms underlying the phenotypical defects of Cx43d/d uteri, we examined whether the loss of Cx43 expression affected the stromal differentiation program. We analyzed the decidual response in Cx43d/d uteri by monitoring the expression of decidual prolactin-related protein (PRP) and prolactin-like protein (PLP), well-known biochemical markers of decidualization (Orwig et al., 1997; Rasmussen et al., 1997; Croze et al., 1990; Lin et al., 1997). As expected, uterine sections from Cx43fl/fl mice exhibited prominent PRP expression in both antimesometrial (AM) and mesometrial (M) areas on day 7 of pregnancy (Fig. 4A). A similar pattern of PRP expression was observed in Cx43-deficient pregnant uterus on this day (Fig. 4B). On day 8 of pregnancy in Cx43fl/fl mice, PRP expression was drastically reduced in the decidual cells at both antimesometrial and mesometrial regions. Only a few cells in the mesometrial region close to the ectoplacental cone retained strong PRP expression (Fig. 4C). By contrast, a strikingly different spatial expression of PRP was seen in Cx43-deficient uteri on day 8 of pregnancy (Fig. 4D). In these mutant uteri, expression of PRP, similar to that seen on day 7 of pregnancy, persisted in the majority of the decidual cells in the antimesometrial and mesometrial areas. A plausible explanation for the absence of timely downregulation of PRP expression in these cells is that they fail to reach a more advanced state of differentiation. When we analyzed PLP expression, it was prominent in the antimesometrial region of uterine sections of Cx43fl/fl mice on day 8 of pregnancy and was markedly reduced in Cx43-deficient uteri (Fig. 4E,F). Collectively, the aberrant expression of both PRP and PLP indicated that the loss of Cx43 expression in the uterine stromal cells leads to an impairment in the proper progression of the decidualization program.
It is important to address whether Cx43 controls stromal decidualization and angiogenesis independently of embryonic development. We, therefore, subjected non-pregnant mice to experimentally induced decidualization in which a mechanical perturbation of the steroid-primed uteri triggers a decidual response in the absence of the implanting embryo (Cheon et al., 2004). Uteri of ovariectomized Cx43fl/fl and Cx43d/d mice were prepared by treating these animals with a well-established regimen of E and P, and then decidualization was initiated in the left uterine horn by injecting 50 µl oil while the right horn was left unstimulated. As shown in Fig. 5A, widespread expression of Cx43 is induced in stromal cells of Cx43fl/fl mice in response to the deciduogenic stimulus. We then examined the gross anatomy of the stimulated and unstimulated uterine horns of Cx43fl/fl and Cx43d/d mice. As expected, the uterine horn of Cx43fl/fl mice exhibited a robust decidual response within 48 hours of receiving the artificial stimulation (Fig. 5B, upper left panel). By contrast, the Cx43-deficient uteri under identical conditions showed significantly reduced decidualization (Fig. 5B, upper right panel). When the decidual response was assessed by measurement of uterine wet weight gain, the Cx43-deficient uteri exhibited a markedly reduced weight gain relative to that seen in the Cx43fl/fl uteri (Fig. 5B, middle panel). We further analyzed the decidualization response of Cx43d/d uteri by monitoring the expression of Hoxa10 and bone morphogenetic protein 2 (Bmp2), factors that are induced in stromal cells during decidualization and that play important regulatory roles during this process (Lim et al., 1999; Lee et al., 2007; Li et al., 2007). As shown in the lower panel of Fig. 5B, when Cx43fl/fl and Cx43-deficient uteri were subjected to artificial decidual stimulation, we observed a marked downregulation of mRNAs corresponding to Hoxa10 and Bmp2 in the uteri lacking Cx43, consistent with the other decidualization defects observed in the conditional mutant mice.
We next analyzed the angiogenic capacity of Cx43-deficient uteri during artificial decidualization. Immunohistochemical analysis of Cx43fl/fl and Cx43-deficient uteri with a Pecam antibody revealed that the artificially stimulated Cx43fl/fl horn displayed an extensive endothelial cell network spanning the endometrial bed (Fig. 5C, left panel). By contrast, similarly treated uterine horns of Cx43d/d mice displayed drastically reduced Pecam staining, indicating that only a rudimentary vasculature is formed (Fig. 5C, right panel). These studies clearly indicate that even in the absence of the conceptus, communication via Cx43 gap junctions plays a crucial role in stromal cell differentiation and angiogenesis in the steroid hormone-primed uterus.
We considered the possibility that the impaired decidualization of the mutant stromal cells might affect the timely production of paracrine regulators from these cells, thereby inhibiting endothelial proliferation or angiogenesis. Ample evidence indicates that Vegf is a potent paracrine stimulator of endothelial cell proliferation and is a crucial angiogenic factor during decidualization (Ferrara et al., 1996; Halder et al., 2000). We, therefore, examined the pattern of Vegf protein expression in Cx43fl/fl and Cx43d/d uteri during the decidualization phase. Widespread expression of Vegf was observed in Cx43fl/fl uteri on days 7 (Fig. 6A, part a) and 8 (Fig. 6A, part b) of pregnancy, particularly in the mesometrial area, which is the primary source of the growing implantation site vasculature. Its spatial expression pattern closely overlapped with that of Pecam, which marked the endothelial network (compare Fig. 3B and Fig. 6A). By contrast, a significant downregulation of Vegf expression, concomitant with the sharp reduction in Pecam immunostaining, was seen in Cx43-deficient uteri (Fig. 6A, part c,d; compare with Fig. 3B, parts d–f). The Vegf expression in Cx43d/d uteri was limited to only a few layers of cells surrounding the implanted embryo, and was markedly reduced in the mesometrial region. We also observed a marked downregulation of mRNAs encoding angiopoietin 2 and angiopoietin 4 in Cx43-deficient uteri during the decidualization phase (Fig. 6B). As these factors are known to play important regulatory roles in endothelial cell proliferation, migration and new blood vessel formation, our findings provide mechanistic insights into the pathways via which stromal Cx43 gap junctions control angiogenesis during decidualization.
To further explore the relationship between Cx43 and Vegf expression, and to test whether this important functional link is conserved among the species, we extended our study to human endometrial stromal cells, which are known to produce these proteins during decidualization (Jahn et al., 1995; Shifren et al., 1996; Granot et al., 2000). We used primary human endometrial stromal cells (HESC-T) that have been immortalized by stable transfection of a gene encoding the catalytic subunit of human telomerase (Krikun et al., 2004). By using these cells, we established a low CX43-expressing human stromal cell line HESC-T3 that is stably transduced with a retroviral vector expressing small interfering RNA (siRNA) targeted to CX43 mRNA, generously provided by Dr Dale Laird (Shao et al., 2005). A control cell line, HESC-TC, containing the same retroviral vector expressing a non-target sequence was also generated. Quantification by real-time RT-PCR indicated that CX43 mRNA levels in HESC-T3 cells were drastically reduced (>90%) relative to those in control HESC-TC cells (data not shown). Correspondingly, western blot analysis demonstrated a marked reduction of CX43 protein in HESC-T3 cells (Fig. 7A). To examine whether the consequence of this forced suppression of CX43 is an inhibition of gap junctions, we used a double dye-labeling technique. As shown in Fig. 7B, gap junction-permeable green calcein dye diffused from injected control HESC-TC cells (yellow arrows, Fig. 7B) to adjacent cells, confirming that functional gap junctions exist between stromal cells. By contrast, the injected dye failed to diffuse from low CX43-expressing HESC-T3 stromal cells. The non-diffusible red DiI marker identifies the microinjected cells. Interestingly, the HESC-T3 cells also failed to undergo morphological decidualization in vitro following treatment with a hormonal cocktail containing E, P and cAMP, whereas the control HESC-TC cells, treated with this cocktail, exhibited distinct epithelioid morphological characteristics (Ryan et al., 1994) that were indicative of their differentiated status (Fig. 7C). These results correlate with the impaired progression through decidualization displayed by the uterine stromal cells of Cx43d/d mice.
We next examined whether this lack of stromal differentiation in the absence of CX43 resulted in differences in protein production from HESC-TC and HECS-T3 cells. Prolactin, a biomarker of decidualization in human endometrial stromal cells, similar to the expression of PRP in the mouse, was undetectable in untreated cells but was induced after 7–11 days incubation with E, P and cAMP. Prolactin production in hormone-treated HESC-T3 cells was reduced by 66±8% relative to control HESC-TC cells (n=3, P<0.02). In addition to a reduction in this classical marker of stromal differentiation, Fig. 7D indicates that basal and phorbol ester (TPA)-induced production of VEGF also was reduced in low CX43 expressing HESC-T3 cells compared with control HESC-TC cells. Quantification of VEGF synthesis was performed in three independent E, P and cAMP-treated cell cultures. In control HESC-TC cells, hormone treatment stimulated VEGF production 11.4±5.7 fold, whereas the hormone-induced augmentation in HESC-T3 cells was only 1.4±0.1-fold (n=3, P<0.04). Our findings indicate that CX43 gap junctions are directly involved in the regulation of VEGF production in human endometrial stromal cells during in vitro decidualization. Furthermore, conservation of the important functional link between CX43 and VEGF expression in both mouse and human stromal cells supports a fundamental role of gap junction communication during uterine angiogenesis.
In rodents, a transient surge of E in the preimplantation phase is essential for initiating implantation of the blastocyst into the uterine epithelium (Psychoyos, 1973; Yoshinaga, 1988). The E-induced delayed implantation in rats and mice faithfully captures this hormonal effect. Although the implantation-inducing action of E in rodents has been known for a long time, the mechanism and mediators of this effect remain largely unknown. Using gene expression profiling, we have identified Cx43 as a target of E regulation in the uterus during delayed implantation. The connexins constitute a large family of gap junction proteins that regulate intercellular communications. Although other members of this family, including Cx26 and Cx31, are expressed in the pregnant mouse uterus (Grummer et al., 1996), our microarray data indicated that Cx43 is the sole member of this family whose uterine expression is induced by E during implantation. Our findings are in agreement with previous reports that Cx43 expression in the uterus is primarily under E regulation (Grummer et al., 2004).
The expression of Cx43 in uterine stromal cells is intimately associated with the decidualization phase of pregnancy. Following blastocyst attachment, the underlying stromal cells undergo extensive proliferation and differentiation that result in their transformation into the decidual cells. In mice and a few other species, decidualization can also be experimentally induced by a variety of artificial stimuli in steroid hormone-primed uteri. We found that the expression of Cx43 is robustly induced in the decidual tissue during both normal and artificial decidualization. This induction of Cx43 is likely to be regulated by E acting via ERα (Esr1 – Mouse Genome Informatics). In support of this view, our recent studies using conditional knockout mice harboring a null mutation of the gene encoding ERα in the uterus have shown that E-induced expression of Cx43 is absent in these mutant mice (M.J.L. and I.C.B., unpublished). A direct regulatory role for ERα in Cx43 expression, however, remains to be established, and would require a detailed analysis of the 5′-flanking regulatory region of the Cx43 gene for the presence of functional ER-binding sites.
Analysis of the Cx43-deficient uteri revealed an impaired decidual response during both normal and artificial decidual reaction. A defect in decidualization could arise from either compromised stromal cell proliferation or an arrest in the differentiation program of these cells. Immunohistochemical studies using the cell proliferation marker Ki67 indicated that Cx43-deficiency did not significantly affect stromal cell proliferation, which occurs predominantly during days 5 and 6 of pregnancy (data not shown). However, in the absence of Cx43 gap junctions, the stromal cells failed to progress properly in the differentiation program initiated in response to a decidual stimulation. This was evidenced by a marked reduction in uterine wet weight gain, which is considered a hallmark of decidualization. Additionally, two well-known markers of uterine stromal differentiation, PRP and PLP, exhibited impaired or aberrant expression in Cx43-deficient uteri during days 7 and 8 of pregnancy. The altered expression of these biomarkers indicated that the loss of Cx43 expression in the uterine stromal cells leads to improper progression of the decidualization program. The defect in stromal differentiation in the absence of Cx43 was further substantiated when we analyzed the uterine expression of Hoxa10 and Bmp2, which are crucial regulators of decidualization. Previous studies have shown that mice harboring a targeted deletion of either the Hoxa10 or the Bmp2 gene exhibit impaired uterine stromal differentiation and are infertile (Lim et al., 1999; Lee et al., 2007). The expression of both of these factors was markedly reduced in Cx43-deficient uteri. Furthermore, we observed that the loss of Cx43 expression in human endometrial stromal cells blocked their differentiation into prolactin-producing decidual cells. Collectively, these results form the basis of the important concept that the formation of Cx43 gap junctions between stromal cells is critical for the efficient and timely progression of the decidualization program.
Our study also suggests that stromal differentiation and angiogenesis are intimately linked processes within the pregnant uterus. Paracrine factors secreted by the decidualizing stromal cells might influence the proliferation and function of uterine endothelial cells in the mesometrial region of the pregnant uterus where neovascularization mostly occurs. Impaired decidualization due to the loss of Cx43 gap junction communication might result in reduced expression and secretion of angiogenic factors by the uterine stromal cells, and might thereby lead to a concomitant impairment in angiogenesis. In strong support of this concept, we observed a markedly reduced expression of Vegf, a potent stimulator of endothelial cell proliferation and a well-known angiogenic molecule, particularly in the mesometrial region of the pregnant Cx43-deficient uterus. Previous studies have shown that the morphogen Bmp2 mediates the enhancement of Vegf expression and neovascularization in xenografts of breast tumors in mice (Raida et al., 2005). It was also demonstrated that Vegf expression in chondrocytes requires cooperative interactions between the Bmp2 and β-catenin signaling pathways (Chen et al., 2008). It is, therefore, conceivable that Bmp2 produced by the decidualizing stromal cells might regulate uterine Vegf expression during early pregnancy. Future studies will evaluate the role of Bmp2 and other stroma-derived factors in the regulation Vegf expression in the decidual uterus.
We also noted that the expression of two additional angiogenesis regulators, angiopoietins 2 and 4, was downregulated in the Cx43-deficient uterus during the decidualization phase. Whereas previous studies established that angiopoietin 2 is required for the sprouting of new blood vessels in adult tissues, recent reports implicated angiopoietin 4 in endothelial cell migration (Gale et al., 2002; Lee et al., 2004). The lack of expression of these crucial angiogenic factors was predictably associated with a dramatic impairment in the formation of neovasculature in pregnant Cx43-deficient uteri, and, consequently, led to poor embryo development and early pregnancy loss. Most importantly, the use of primary cultures of human endometrial stromal cells allowed us to establish that the interrelationship between stromal CX43 expression, the progression of decidualization, and the production of VEGF by the decidual cells also exists in the human. Our study, therefore, uncovered a conserved, fundamental role of Cx43 gap junctions in maintaining the stromal differentiation program and supporting angiogenesis in the uterus during early pregnancy. Another tantalizing possibility is that the Cx43 gap junctions additionally play a role in the regulation of communication between the maternal decidua and the conceptus. Further studies will be required to carefully examine whether Cx43 expression is linked to proper functioning of the extraembryonic tissues, such as the parietal endoderm, giant cells and the ectoplacental cone.
Gap junction channels allow direct exchange of ions, second messengers, metabolites, and other small molecules (up to ~1200 Da) between the cytoplasms of adjacent cells. This type of intercellular coupling is known to regulate cell proliferation and differentiation (Lo and Gilula, 1979; Simon and Goodenough, 1998; Evans and Martin, 2002). The identity of the intercellular signal(s) being exchanged via the stromal gap junction during decidualization needs to be established. Within the pregnant uterus, stromal differentiation proceeds in a strictly coordinated manner, spreading spatially from the antimesometrial to the mesometrial side as the pregnancy advances. It is conceivable that stromal cells that are more advanced in the differentiation program could facilitate the progression of their less differentiated neighbors by establishing direct contact with these cells. Once the gap junctions are formed, crucial signaling molecules may pass from the donor to the recipient cells via these connections. These regulatory molecules, which may include second messengers, such as cyclic nucleotides, calcium ions or prostaglandins, are likely to impact the gene expression program and differentiation fates of the recipient stromal cells, altering their ability to produce Vegf, angiopoetin 2, angiopoetin 4, and possibly other paracrine angiogenic effectors. In support of this concept, cAMP and phorbol ester-dependent signaling pathways were found to enhance VEGF expression by human endometrial stromal cells (Popovici et al., 1999; Fig. 7D). cAMP was also implicated as the signaling molecule that passes through the gap junctions to influence the adrenocorticotropin-stimulated growth and steroidogenic function of adrenal cells (Murray and Fletcher, 1984; Shah and Murray, 2001). We postulate that a similar mode of intercellular coupling via Cx43 gap junctions may underlie the unique spatiotemporal appearance of the differentiation markers and the coordinated production of angiogenic regulators in the uterus during early pregnancy.
In summary, the present study revealed a central role for Cx43-containing stromal gap junctions in the establishment of an elaborate vascular network within the endometrial bed that is essential for successful implantation and subsequent embryonic growth. The ovarian hormone dependence of Cx43 functionally regulates gap junction communication among stromal cells, advancing the process of decidualization and stimulating these cells to produce crucial paracrine effectors, such as Vegf. Most importantly, a novel, linear molecular pathway has emerged providing yet another link between nuclear actions of steroid hormones and cellular signaling at the level of the plasma membrane. Ultimately, these molecules control stromal differentiation and angiogenesis during early pregnancy.
This work was supported by the NICHD/NIH, through cooperative agreement U54 HD055787, as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by National Institutes of Health Grants R01 HD-43381 (I.C.B.), R01 HD-44611 (M.K.B.), R01 HD-33238 (R.N.T.) and R01 HD-55379 (N.S.). This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR16515-01 from the National Center for Research Resources, National Institutes of Health (I.C.B.).